 |
answer text |
<p>Public Health England has not made any formal assessment of the impact of the provision
of housing on treatment completion for vulnerable populations in the United Kingdom
suffering from hepatitis B, and hepatitis C.</p><p> </p><p> </p><p> </p><p>Our estimates
of the prevalence of chronic hepatitis B and C infection in the UK population are
180,000<sup>1</sup> and 214,000[2] respectively.</p><p> </p><p> </p><p> </p><p>Studies
of hepatitis B and C in the UK homeless population are limited but a recent survey
of people who inject drugs found that those who had ever been homeless were more likely
to have antibodies against hepatitis C (42%) than those that were in stable accommodation
(34%)<sup>3</sup>.</p><p> </p><p> </p><p> </p><p> </p><p> </p><p><em>Notes:</em></p><p>
</p><p> </p><p> </p><p>[1]Department of Health. (2002a) Getting ahead of the curve:
a strategy for combating infectious diseases (including other aspects of health protection).
A report by the Chief Medical Officer.London</p><p> </p><p> </p><p> </p><p>2Hepatitis
C in the UK, Annual Report 2014 Public Health England.</p><p> </p><p>https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/337115/HCV_in_the_UK_2014_24_July.pdf</p><p>
</p><p> </p><p> </p><p>3Health Protection Agency, Health Protection Scotland, National
Public Health Service for Wales, CDSC Northern Ireland, CRDHB. Shooting Up: Infections
among injecting drug users in the United Kingdom 2008. London: Health Protection Agency,
October 2009.</p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p>
|
|
